Article: J.M. Dutton & Associates Announces Investment Opinion: Medix Resources Speculative Buy Rating In Initial Report Issued By Dutton & Associates.

Business Editors

NOTE TO EDITORS: The following is an investment opinion issued

by J.M. Dutton & Associates

EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Sept. 3, 2002

J.M. Dutton & Associates initiates research coverage of Medix Resources, Inc. (AMEX:MXR) with a Speculative Buy rating and a 12-month $2.60 price target (recent price $.39). The 12-page report by JM Dutton senior analyst Paul J. Resnick, CFA is available at www.jmdutton.com as well as from Zacks, First Call, Multex, and other leading financial portals.

Medix Resources is a healthcare information technology company with national customer contracts with WellPoint ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!